Back to all studies
RecruitingNCT05540288

NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions

This study is recruiting. It focuses on addiction and currently lists participation information in France.

AddictionDrugOver 18 Years
In plain English

Key information made simple

What is this study testing?

This study is testing whether Nalmefene may be useful for adults experiencing addiction.

What would participation involve?

Participants may receive Nalmefene, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in France.

Who is it mainly for?

This study appears to be mainly for adults with addiction.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: March 31, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
266
Sponsor
Nantes University Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
France
Age range
Over 18 Years
Official registry ID
NCT05540288
Official title
NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions

Want help reviewing this study?

Loading the security check...
Study ID: NCT05540288. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

France · 13 sites
  • CHU de Besançon
    Besançon
    Site status: Not Yet Recruiting
  • CHU de Bordeaux
    Bordeaux
    Site status: Recruiting
  • CHRU de Brest
    Brest
    Site status: Recruiting
  • CHU de Clermont Ferrand
    Clermont-Ferrand
    Site status: Recruiting
  • CHU de Dijon
    Dijon
    Site status: Not Yet Recruiting
  • CH de La Rochelle
    La Rochelle
    Site status: Recruiting
  • Hospices Civils de Lyon
    Lyon
    Site status: Recruiting
  • CHU de Montpellier
    Montpellier
    Site status: Not Yet Recruiting
  • CHU de Nantes
    Nantes
    Site status: Recruiting
  • CHU de Nîmes
    Nîmes
    Site status: Recruiting
  • Hôpitaux Universitaires de Strasbourg
    Strasbourg
    Site status: Recruiting
  • CHRU de Tours
    Tours
    Site status: Recruiting
  • Hôpital Paul Brousse
    Villejuif
    Site status: Recruiting
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring behavioral or lifestyle intervention for people with addiction. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Nalmefene, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Are there criteria about substance use or wanting to reduce it?

The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Nantes University Hospital, which appears to be a hospital or academic medical center. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as recruiting. Individual sites may have different statuses. The research team must confirm whether a site is open and whether you meet the criteria.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me